Nimotuzumab in Children With Intrinsic Pontine Glioma

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

January 31, 2012

Conditions
Diffuse Instrinsic Ponitine Glioma
Interventions
DRUG

nimotuzumab

monoclonal antibody

Trial Locations (1)

53113

University Bonn, Children's Medical Hospital, Bonn

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Children's Medical Hospital, University of Bonn, Germany

OTHER

collaborator

University of Wuerzburg

OTHER

collaborator

Dept. of Statistics, University of Dortmund, Germany

OTHER

collaborator

CRM Biometrics GmbH

INDUSTRY

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany

OTHER

collaborator

Children's Medical Hospital, University of Homburg/Saar, Homburg/Saar, Germany

OTHER

collaborator

Children's Medical Hospital, Medical School Hannover, Hannover, Germany

UNKNOWN

collaborator

Children's Medical Hospital, University of Leipzig, Leipzig, Germany

OTHER

collaborator

Children's Medical Hospital, University of Muenster, Muenster, Germany

OTHER

collaborator

Burdenko Neurosurgery Institute

OTHER

collaborator

Istituto Nazinonale Tumori, Div. of Paediatric Oncology,Milano, Italy

UNKNOWN

lead

Oncoscience AG

INDUSTRY